HK1025793A1 - Hepatitis c receptor protein cd81 - Google Patents
Hepatitis c receptor protein cd81Info
- Publication number
- HK1025793A1 HK1025793A1 HK00104953.7A HK00104953A HK1025793A1 HK 1025793 A1 HK1025793 A1 HK 1025793A1 HK 00104953 A HK00104953 A HK 00104953A HK 1025793 A1 HK1025793 A1 HK 1025793A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hepatitis
- receptor protein
- protein
- diagnosis
- therapy
- Prior art date
Links
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 102000005962 receptors Human genes 0.000 title 1
- 108020003175 receptors Proteins 0.000 title 1
- 101710165845 CD81 protein Proteins 0.000 abstract 1
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9721182.5A GB9721182D0 (en) | 1997-10-06 | 1997-10-06 | Hepatitis C receptor protein |
GBGB9813560.1A GB9813560D0 (en) | 1998-06-23 | 1998-06-23 | Hepatitis C Receptor Protein |
PCT/IB1998/001628 WO1999018198A1 (en) | 1997-10-06 | 1998-10-06 | Hepatitis c receptor protein cd81 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1025793A1 true HK1025793A1 (en) | 2000-11-24 |
Family
ID=26312375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00104953.7A HK1025793A1 (en) | 1997-10-06 | 2000-08-09 | Hepatitis c receptor protein cd81 |
Country Status (13)
Country | Link |
---|---|
US (4) | US7097987B2 (xx) |
EP (1) | EP1021534B1 (xx) |
JP (3) | JP4198882B2 (xx) |
AT (1) | ATE449847T1 (xx) |
AU (1) | AU9363398A (xx) |
CA (1) | CA2304796C (xx) |
CY (1) | CY1109868T1 (xx) |
DE (1) | DE69841322D1 (xx) |
DK (1) | DK1021534T3 (xx) |
ES (1) | ES2334727T3 (xx) |
HK (1) | HK1025793A1 (xx) |
PT (1) | PT1021534E (xx) |
WO (1) | WO1999018198A1 (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030113914A1 (en) * | 2001-12-10 | 2003-06-19 | Isis Pharmaceuticals, Inc. | Antisense modulation of CD81 expression |
US20020160936A1 (en) * | 1999-09-29 | 2002-10-31 | Howard J. Worman | Hcv e2 protein binding agents for treatment of hepatitis c virus infection |
GB9927320D0 (en) * | 1999-11-18 | 2000-01-12 | Chiron Spa | Exosome separation |
WO2001047545A1 (fr) * | 1999-12-28 | 2001-07-05 | Sumitomo Pharmaceuticals Company, Limited | Produits therapeutiques et prophylactiques pour l'hepatique chronique |
WO2001058459A1 (en) * | 2000-02-14 | 2001-08-16 | Mitsubishi Pharma Corporation | Remedies for hepatitis c |
JP2001299140A (ja) * | 2000-04-24 | 2001-10-30 | Sumitomo Pharmaceut Co Ltd | Hcvを増幅しうる細胞及び非ヒト動物 |
GB0016361D0 (en) * | 2000-07-03 | 2000-08-23 | Chiron Spa | Structure-based HCV drug design |
US8039602B2 (en) | 2000-10-31 | 2011-10-18 | Ryogen Llc | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
US20030013081A1 (en) | 2001-06-26 | 2003-01-16 | Olson William C. | Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
JP4221292B2 (ja) * | 2001-08-10 | 2009-02-12 | 田辺三菱製薬株式会社 | C型肝炎治療薬 |
DK1662007T3 (da) * | 2003-08-28 | 2011-06-14 | Dainippon Sumitomo Pharma Co | Forebyggende middel eller lægemiddel til inflammatoriske tarmsygdomme indeholdende anti-CD81-antistof som den aktive bestanddel |
TW200813086A (en) | 2006-05-11 | 2008-03-16 | Hoffmann La Roche | Immunereconstituted mouse |
NL2001318C2 (nl) | 2008-02-25 | 2009-08-26 | Schuitemaker Mach Bv | Inrichting en werkwijze voor het snijden van kuilvoer. |
WO2012107589A1 (en) | 2011-02-11 | 2012-08-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of hcv infections |
EP2803673A4 (en) | 2011-12-26 | 2016-03-23 | Shionogi & Co | MONOCLONAL ANTIBODY FOR THE DETECTION OF EXOSOMES |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341629C (en) | 1987-11-18 | 2012-05-08 | Chiron Corporation | Hepatitis c diagnostics and vaccines |
US5631407A (en) * | 1989-03-10 | 1997-05-20 | The Trustees Of Columbia University In The City Of New York | Transgenic mouse expressing DNA sequences encoding the human poliovirus receptor |
UA50829C2 (uk) | 1989-03-17 | 2002-11-15 | Чірон Корпорейшн | Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл |
WO1991007489A1 (en) * | 1989-11-22 | 1991-05-30 | Childrens Hospital Of Los Angeles | Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia |
GB9416671D0 (en) | 1994-08-17 | 1994-10-12 | Biocine Spa | Assay |
GB9517926D0 (en) | 1995-09-01 | 1995-11-01 | Biocine Spa | Binding protein |
US6031088A (en) * | 1996-05-23 | 2000-02-29 | Albert Einstein College Of Medicine Of Yeshiva University | Polycystic kidney disease PKD2 gene and uses thereof |
US7491865B2 (en) * | 2004-08-19 | 2009-02-17 | Fred Hutchinson Cancer Research Center | Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene |
-
1998
- 1998-10-06 EP EP98946642A patent/EP1021534B1/en not_active Expired - Lifetime
- 1998-10-06 CA CA2304796A patent/CA2304796C/en not_active Expired - Fee Related
- 1998-10-06 DK DK98946642.0T patent/DK1021534T3/da active
- 1998-10-06 PT PT98946642T patent/PT1021534E/pt unknown
- 1998-10-06 AT AT98946642T patent/ATE449847T1/de active
- 1998-10-06 ES ES98946642T patent/ES2334727T3/es not_active Expired - Lifetime
- 1998-10-06 JP JP2000514996A patent/JP4198882B2/ja not_active Expired - Fee Related
- 1998-10-06 AU AU93633/98A patent/AU9363398A/en not_active Abandoned
- 1998-10-06 DE DE69841322T patent/DE69841322D1/de not_active Expired - Lifetime
- 1998-10-06 WO PCT/IB1998/001628 patent/WO1999018198A1/en active Application Filing
-
2000
- 2000-08-09 HK HK00104953.7A patent/HK1025793A1/xx not_active IP Right Cessation
-
2004
- 2004-06-03 US US10/859,700 patent/US7097987B2/en not_active Expired - Fee Related
-
2006
- 2006-07-28 US US11/495,151 patent/US20070087407A1/en not_active Abandoned
-
2008
- 2008-08-07 JP JP2008204853A patent/JP2009035553A/ja not_active Withdrawn
- 2008-09-02 US US12/231,370 patent/US20090025098A1/en not_active Abandoned
-
2010
- 2010-01-29 CY CY20101100095T patent/CY1109868T1/el unknown
-
2011
- 2011-06-24 US US13/167,887 patent/US20120066779A1/en not_active Abandoned
-
2012
- 2012-01-04 JP JP2012000122A patent/JP2012125246A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US7097987B2 (en) | 2006-08-29 |
CY1109868T1 (el) | 2014-09-10 |
US20120066779A1 (en) | 2012-03-15 |
JP2012125246A (ja) | 2012-07-05 |
JP2001519150A (ja) | 2001-10-23 |
JP2009035553A (ja) | 2009-02-19 |
JP4198882B2 (ja) | 2008-12-17 |
EP1021534B1 (en) | 2009-11-25 |
ES2334727T3 (es) | 2010-03-15 |
WO1999018198A1 (en) | 1999-04-15 |
AU9363398A (en) | 1999-04-27 |
US20070087407A1 (en) | 2007-04-19 |
CA2304796C (en) | 2013-12-03 |
US20090025098A1 (en) | 2009-01-22 |
US20040258694A1 (en) | 2004-12-23 |
PT1021534E (pt) | 2010-03-03 |
DK1021534T3 (da) | 2010-02-01 |
EP1021534A1 (en) | 2000-07-26 |
ATE449847T1 (de) | 2009-12-15 |
CA2304796A1 (en) | 1999-04-15 |
DE69841322D1 (de) | 2010-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109868T1 (el) | Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c | |
CY1111863T1 (el) | Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
NO982062D0 (no) | Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav | |
IL141021A (en) | Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases | |
EP0671920A4 (en) | AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES. | |
DK1409544T3 (da) | Humane DR4-antistoffer og anvendelser deraf | |
ATE510552T1 (de) | Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors | |
DK1181319T3 (da) | Kimære DR4-antistoffer og anvendelser deraf | |
DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
PL340465A1 (en) | Antibodies against phosphorylated vasp (vasodilating agent stimulated phosphoprotein) hybridom cells for obtaining them and their application | |
DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
ID23184A (id) | Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi | |
DK0649433T3 (da) | Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne. | |
BR0207327A (pt) | Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos | |
PT1196188E (pt) | Anticorpos monoclonais selectivos para o fcv e sua utilizacao para o tratamento de doencas associadas ao fcv | |
DE50210279D1 (de) | Screeningverfahren mit bnpi und dnpi | |
AU7079300A (en) | Compositions and methods for the treatment of immune related diseases | |
AU653332B2 (en) | Synthetic peptides which contain sequences from factor VIIa, and the use thereof | |
DE59911103D1 (de) | ISOLIERTE UND GEREINIGTE HUMANE LÖSLICHE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGC ALPHA1/BETA1) | |
GB9723630D0 (en) | M.vaccae preparation and its use | |
EP1878795A3 (en) | Compositions and methods for the treatment of immune related diseases | |
UA28518A (uk) | Спосіб визначення алергену у хворих на лікарську хворобу |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151006 |